ArticlePLoS pathogens2025
Capsular polysaccharide of Mycoplasma mycoides subsp. capri contributes to phenotypic diversity promoting distinctive immune responses.
Article in PLoS pathogens, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Bos indicus cattle resistant to digital dermatitis exhibit a balanced proinflammatory cytokine response upon exposure to Treponema phagedenis in contrast to Bos taurus cattle.Veterinary research · 2026Article
- Article
- Immune responses of Bos indicus versus Bos taurus cattle towards Bluetongue virus or Schmallenberg virus differ significantly.Communications biology · 2026Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Mollicutes are minute cell wall less bacteria encompassing important pathogens. We show that pathogenic Mycoplasma mycoides subsp. capri (Mmc) can switch expression of capsular polysaccharide (CPS), which creates phenotypic diversity and has dramatic repercussions on immune responses. To characterize the immune responses, we employed the highly virulent Mmc strain GM12 as well as an engineered CPS-deficient mutant in a set of assays employing primary blood cells from its native caprine host and cattle. Primary blood cells stimulated with GM12 showed only very moderate effects on cell viability as well as activation marker expression supporting an immunological furtiveness-like lifestyle. Interestingly, GM12 showed the capacity to survive and resist inside monocyte-derived macrophages (MDMs), which fosters dissemination and persistence in the host. Stimulation with the CPS-deficient mutant which exposes surface proteins including lipoproteins, increased cell death, strongly suppressed expression of major histocompatibility complex on antigen-presenting cells and induced secretion of several pro-inflammatory cytokines/chemokines which is a clinical hallmark in infected animals. Moreover, the CPS-deficient mutant elicited inflammatory cell death in MDMs. In conclusion, we showed that Mmc can switch the expression of CPS, which leads to different immunological trajectories paving the way for clinical disease, dissemination and persistence in the host.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.